Vitruvias Therapeutics
Latest round
- Series A
Last raised
- Jan 2018
Total raised
- $12M
Investors
- 2
About Vitruvias Therapeutics
Vitruvias Therapeutics, Inc.Founded in 2013 and headquartered in Auburn, US, Vitruvias Therapeutics, Inc. is involved in the production of generic drugs. The company's founders, Bryce Harvey and Carl Whatley, have established a firm that has made three deals since inception.Vitruvias Therapeutics specializes in developing and distributing generic pharmaceuticals, including Aminocaproic Acid Tablets, Cyanocobalamin Injection, Propafenone Hydrochloride Extended-Release Capsules, Pramipexole Dihydrochloride Extended-Release Tablets, and Bupropion Hydrochloride Extended-Release Tablets. These products address critical health conditions such as bleeding disorders, vitamin deficiencies, cardiac arrhythmias, Parkinson's disease, and depression.S.The revenue of Vitruvias Therapeutics is mainly derived from business-to-business transactions with healthcare organizations, pharmacies, and wholesalers through bulk orders and contracts.S. pharmaceutical landscape, employing competitive pricing strategies for their generic products, which are typically lower than branded options.In January 2018, Vitruvias Therapeutics, Inc. The company is focused on launching additional medications to address unmet medical needs and intends to explore international markets for distribution.
Who invested in Vitruvias Therapeutics
2 investors across 1 round
See all investors in Vitruvias Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 5, 2018
Amount
$12M
Investors
Questions about Vitruvias Therapeutics
Who invested in Vitruvias Therapeutics?
Vitruvias Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vitruvias Therapeutics raised?
Vitruvias Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vitruvias Therapeutics last raise money?
Vitruvias Therapeutics's most recent round on record is a Series A, in Jan 2018.
What does Vitruvias Therapeutics do?
Vitruvias Therapeutics is a pharmaceuticals company.
Where is Vitruvias Therapeutics headquartered?
Vitruvias Therapeutics is headquartered in Auburn, US.
Which VCs invest in companies like Vitruvias Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vitruvias Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Vitruvias Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.